CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020	[1]
Current assets:
Cash and cash equivalents	$ 43,265	$ 246,487
Related party receivables from collaborative arrangements	104,262	93,931
Prepaid expenses and other current assets	734	1,640
Total current assets	148,261	342,058
Property and equipment, net	19	28
Equity and long-term investments	473,677	438,258
Capitalized fees paid to a related party, net	118,341	125,253
Deferred tax assets, net	48,690	93,759
Other assets	162	214
Total assets	789,150	999,570
Current liabilities:
Accounts payable	30	66
Accrued personnel-related expenses	389	490
Accrued interest payable	4,152	4,152
Other accrued liabilities	800	1,402
Total current liabilities	5,371	6,110
Long-term debt, net of discount and issuance costs	389,989	385,517
Other long-term liabilities	45	106
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock: $0.01 par value, 230 shares authorized, no shares issued and outstanding	0	0
Common stock: $0.01 par value, 200,000 shares authorized, 69,495 and 101,392 issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	695	1,014
Treasury stock: at cost, 32,005 and 0 shares at June 30, 2021 and December 31, 2020, respectively	(393,829)	0
Additional paid-in capital	1,261,845	1,260,900
Accumulated deficit	(538,931)	(722,002)
Total Innoviva stockholders' equity	329,780	539,912
Noncontrolling interest	63,965	67,925
Total stockholders' equity	393,745	607,837
Total liabilities and stockholders' equity	$ 789,150	$ 999,570

[1] Consolidated balance sheet as of December 31, 2020 has been derived from audited consolidated financial statements.